Compare VYGR & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYGR | FRAF |
|---|---|---|
| Founded | 2013 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 206.3M |
| IPO Year | 2015 | N/A |
| Metric | VYGR | FRAF |
|---|---|---|
| Price | $4.15 | $56.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 468.2K | 53.4K |
| Earning Date | 11-10-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | N/A | ★ 9.43 |
| EPS | N/A | ★ 3.50 |
| Revenue | $31,316,000.00 | ★ $77,783,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $71.78 | N/A |
| P/E Ratio | ★ N/A | $16.03 |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $2.65 | $28.01 |
| 52 Week High | $6.47 | $56.84 |
| Indicator | VYGR | FRAF |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 76.49 |
| Support Level | $4.24 | $55.61 |
| Resistance Level | $4.58 | $56.84 |
| Average True Range (ATR) | 0.23 | 1.18 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 48.52 | 84.33 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.